Literature DB >> 572511

Experimental coonhound paralysis: animal model of Guillain-Barré syndrome.

D F Holmes, R D Schultz, J F Cummings, A deLahunta.   

Abstract

Coonhound paralysis (CHP), a polyradiculoneuritis of dogs that resembles the human Guillain-Barré syndrome, was experimentally reproduced by inoculating a dog with raccoon saliva. The test animal was a coonhound that had previously sustained two naturally occurring attacks of CHP. Success in inducing the disease strengthened the notion that raccoon saliva contains the etiologic factor for CHP and that only specifically susceptible dogs are at risk of developing CHP when exposed to this factor.

Entities:  

Mesh:

Year:  1979        PMID: 572511     DOI: 10.1212/wnl.29.8.1186

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

1.  Coonhound paralysis. Further clinical studies and electron microscopic observations.

Authors:  J F Cummings; A de Lahunta; D F Holmes; R D Schultz
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

2.  Acute idiopathic polyradiculoneuritis concurrent with acquired myasthenia gravis in a West Highland white terrier dog.

Authors:  Gabriela Dumitrita Stanciu; Gheorghe Solcan
Journal:  BMC Vet Res       Date:  2016-06-14       Impact factor: 2.741

3.  Investigation of the Role of Campylobacter Infection in Suspected Acute Polyradiculoneuritis in Dogs.

Authors:  L Martinez-Anton; M Marenda; S M Firestone; R N Bushell; G Child; A I Hamilton; S N Long; M A R Le Chevoir
Journal:  J Vet Intern Med       Date:  2018-01-22       Impact factor: 3.333

Review 4.  Diagnosis and Treatment of Lower Motor Neuron Disease in Australian Dogs and Cats.

Authors:  A M Herndon; A T Thompson; C Mack
Journal:  J Vet Med       Date:  2018-08-06

5.  Spontaneous peripheral neuritis in two electric eels (Electrophorus electricus).

Authors:  Nahid Rahman; Chiho Kezuka; Nobuyuki Higashiguchi; Naoya Kosaka; Takeshi Izawa; Jyoji Yamate; Mitsuru Kuwamura
Journal:  J Vet Med Sci       Date:  2019-03-05       Impact factor: 1.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.